JDS Pharmaceuticals
2004
FOUNDED
PRIVATE
STATUS
M&A
LATEST DEAL TYPE
2
FINANCING ROUNDS
Description
Provider of services in in the acquisition, development, and marketing of in-line and late-stage developmental pharmaceutical products. The company offers Pexeva for major depressive disorders, panic disorders, and obsessive compulsive disorders; and Lithobid for bipolar disorders. It identifies, develops, and delivers safe medicines.
Website
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
- 405 Lexington Avenue
- The Chrysler Building, 59th Floor
- New York, NY 10174
- United States
+1 (212) 000-0000
JDS Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore JDS Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookJDS Pharmaceuticals Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Phillip Satow | Chairman & Chief Executive Officer | ||
| Daniel Kreisler | Vice President |
2 Former Executives
You’re viewing 2 of 4 executives. Get the full list »JDS Pharmaceuticals Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000000 00000 | JDS Pharmaceuticals | Chairman & Chief Executive Officer | 000 0000 |
3 Former Board Members
You’re viewing 1 of 4 board members. Get the full list »